Toda, Japan

Keisuke Terashima


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Yono, JP (2001)
  • Toda, JP (2004)

Company Filing History:


Years Active: 2001-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keisuke Terashima: Innovator in Antiviral Compounds

Introduction

Keisuke Terashima is a notable inventor based in Toda, Japan. He has made significant contributions to the field of antiviral agents, particularly through his innovative work on peptide compounds. With a total of 2 patents, Terashima's research has the potential to impact the treatment of viral infections.

Latest Patents

Among his latest patents are the development of dipeptide compounds and their use as antiviral agents. Additionally, he has created tripeptide compounds that serve as anti-AIDS medicine. One of his novel tripeptide compounds is represented by a specific general formula, which exhibits superior HIV protease inhibition activity. This compound is included in an anti-AIDS medicine that comprises it as an effective component along with a pharmaceutically acceptable salt.

Career Highlights

Throughout his career, Terashima has worked with prominent companies such as Sumitomo Pharmaceuticals Company Limited and Japan Energy Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in antiviral research.

Collaborations

Some of his notable coworkers include Tsutomu Mimoto and Satoshi Nojima. Their collaborative efforts have further enhanced the research and development of antiviral compounds.

Conclusion

Keisuke Terashima's work in the field of antiviral agents showcases his dedication to innovation and research. His contributions through patents and collaborations highlight the importance of scientific advancements in combating viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…